{"title":"社论:开发神经退行性疾病的个性化治疗:基因组学和新技术在确定可采取行动的目标和开发罕见疾病干预措施方面的作用","authors":"Anja Kovanda, Sabina Vatovec, V. Rački","doi":"10.3389/fnins.2024.1403015","DOIUrl":null,"url":null,"abstract":"role","PeriodicalId":509131,"journal":{"name":"Frontiers in Neuroscience","volume":"6 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Editorial: Developing personalized treatment in neurodegenerative disorders: role of genomics and novel technologies in identifying actionable targets and developing interventions in rare-diseases\",\"authors\":\"Anja Kovanda, Sabina Vatovec, V. Rački\",\"doi\":\"10.3389/fnins.2024.1403015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"role\",\"PeriodicalId\":509131,\"journal\":{\"name\":\"Frontiers in Neuroscience\",\"volume\":\"6 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Neuroscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fnins.2024.1403015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fnins.2024.1403015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Editorial: Developing personalized treatment in neurodegenerative disorders: role of genomics and novel technologies in identifying actionable targets and developing interventions in rare-diseases